3Lee LH. Low molecular weight heparins indications and use. Medical Progress, Sea,1997,24(1):5.
4Stephen B, Williams BS, Jorse A, et al. Impaired nitric oxidemediated vasodilation in patients with non-insulin-dependent diabetes mellitus.J Am Coll Cardiol,1996,27:567.
7Animal J , Bridery F , Wolf M. Antibodicsto, maromolecular PF4-heparin complexes in heparin induced thromboeytopenia[J].Thromb Hacmost , 1995, 73:21.
8Gurfinkel EP, Manos EJ, Mejail RL, et al. Low molecular weight heparin versus regular heparin or aspirin in the treatment of unstable angina and sident ischemia[J]. J Am Con Cordial,1995, 26(2): 313.
